Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry

被引:25
作者
Gomez, HF [1 ]
McClafferty, HH [1 ]
Flory, D [1 ]
Brent, J [1 ]
Dart, RC [1 ]
机构
[1] DENVER HLTH & HOSP,ROCKY MT POISON & DRUG CTR,DENVER,CO
关键词
D O I
10.1016/S0196-0644(97)70073-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To investigate the effect of an orally administered premixed slurry of deferoxamine mesylate (DFO) and activated charcoal (AC) on the gastrointestinal (GI) absorption of ferrous sulfate under physiologic conditions. Methods: This was a prospective, crossover, controlled human volunteer study. Participants were healthy adult subjects aged 25 to 38 years. Volunteers ingested either 5 mg/kg ferrous sulfate alone, 5 mg/kg ferrous sulfate added to 25 g of 20% (weight/volume) AC, or 5 mg/kg ferrous sulfate added to a premixed slurry consisting of 8 g of DFO and 25 g of 20% (weight/volume) AC. The same group of volunteers was used in each limb of the study. Serum iron concentrations were measured at baseline and at 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, and 24 hours after ingestion for all subjects. Urinary iron was determined over the first 12 hours after ingestion for each limb. The maximum iron concentration (Cmax), the time to maximum iron concentration (Tmax), and the area under the curve (AUG) were compared for all three limbs. Results: The AUC (P=.042) and Cmax (P=.017) were significantly lower in all subjects in the DFO/AC limb compared with the two control limbs. There was no significant difference in the Tmax iron concentration (P=.77). In the ferrous sulfate control limb, female volunteers had a significantly higher mean Cmax (P=.008) and AUC (P=.014) than males. Iron was undetectable in all baseline and 12-hour urine collections. Conclusion: In this model, a premixed 1:3(weight/weight) DFO/AC slurry reduced the GI absorption of ferrous sulfate in adult volunteers under physiologic conditions.
引用
收藏
页码:587 / 592
页数:6
相关论文
共 25 条
[1]  
*AM SOC HPSP PHARM, 1993, AHFS DRUG INF 1990, P1874
[2]  
BANNER W, 1986, PEDIATR CLIN N AM, V33, P393
[3]  
CHANG TMS, 1983, LANCET, V2, P1051
[4]   IRON POISONING - AN INVITRO COMPARISON OF BICARBONATE AND PHOSPHATE LAVAGE SOLUTIONS [J].
CZAJKA, PA ;
KONRAD, JD ;
DUFFY, JP .
JOURNAL OF PEDIATRICS, 1981, 98 (03) :491-494
[5]  
DEAN B, 1988, VET HUM TOXICOL, V30, P313
[6]   INVIVO EFFECTIVENESS OF ORAL COMPLEXATION AGENTS IN THE MANAGEMENT OF IRON POISONING [J].
DEAN, BS ;
KRENZELOK, EP .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1987, 25 (03) :221-230
[7]   ADSORPTION OF DRUGS AND POISONS BY ACTIVATED CHARCOAL [J].
DECKER, WJ ;
COMBS, HF ;
CORBY, DG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1968, 13 (03) :454-&
[8]  
DIPIRO JT, 1988, CONCEPTS CLIN PHARM
[9]  
DOLLERY C, 1991, THERAPEUTIC DRUGS, pD28
[10]  
GOMEZ HF, 1993, VET HUM TOXICOL, V35, P366